healthcare professionals

Results for the first quarter of 2020 are ready 14.05

Results and webcast
CEO update

“We work systematically to strengthen our core business by delivering growth through the introduction of new products in existing markets and expanding products to new geographies. We have started and will continue the tedious process to increase company value by owning new products and brands. As a third step, we have been and will actively continue to source and evaluate M&A opportunities to deliver sustainable growth with the objective of building Navamedic to a leading Nordic pharmaceutical company with a footprint in North Europe and other selected countries,” says Kathrine Gamborg Andreassen, CEO of Navamedic ASA.

Read more
Meet us at exhibitions and fairs

Unfortunately, due to Covid-19.  Exhibitions are postponed or canceled until further notice

Text
Country
Date
Text
Country
Date
Canceled
Sweden
20.03.20
Canceled
Sweden
20.03.20
Canceled
Norway
06.03.20
Canceled
Norway
06.03.20